company score funding investors employees industries biz model city contact
NeurosterixJUST ADDED HIRING

Advanced allosteric modulator therapeutics developer for neurological disorders.

56
$63M · Series A Xontogeny, Perceptive Advisors, Acorn Bioventures 1 to 10 Health Tech, Biotech Geneva, Switzerland •••••••••••@neurosterix.com
Nouscom HIRING

Viral vector-based cancer vaccines developer.

51
$82M · Series C Bpifrance, 5AM Ventures, Abingworth 1 to 10 Health Tech, Biotech B2C Basel, Switzerland •••••••••••@nouscom.com
Memo Therapeutics

Antibody discovery and human immune repertoire analysis platform.

42
$27M · Series C Vesalius Biocapital Partners, Adjuvant Capital, Pureos Bioventures 11 to 50 Health Tech, Biotech B2B Zürich, Switzerland •••••••••••@memo-therapeutics.com
Vandria

Small molecule mitophagy inducers developer.

42
$20M · Series A ND Capital 1 to 10 Health Tech, Biotech Lausanne, Switzerland •••••••••••@vandria.com
Cradle

Generative AI platform for protein design and engineering.

42
$24M · Series A Index Ventures, Kindred Capital 11 to 50 AI, Biotech B2B Zürich, Switzerland •••••••••••@cradle.bio
Noema Pharma

Clinical-stage central nervous system (CNS) technology.

37
$110M · Series B Sofinnova Partners, Forbion Capital Partners, BioMedPartners 1 to 10 Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@noemapharma.com
MindMaze

MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat and rehab patients.

37
$125M Hambro Perks Ltd. 101 to 250 Health Tech, AR / VR, Biotech, Deep Tech, Business Intelligence B2B Lausanne, Switzerland •••••••••••@mindmaze.com
Anjarium Biosciences

Gene therapy research to tackle genetic diseases.

37
$59M · Series A Gimv 1 to 10 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@anjarium.com
Isospec Analytics SAJUST ADDED HIRING

Molecular analysis technology developer.

37
$1M · Pre Seed Tiny VC, Founderful, another.vc 1 to 10 Biotech B2B Lausanne, Switzerland •••••••••••@isospecanalytics.com
Stalicla

Precision medicine developer for neuropsychiatric and neurological disorders.

37
$13M · Series B SPRIM Global Investments 11 to 50 Biotech Geneva, Switzerland •••••••••••@stalicla.com
TOLREMO therapeutics

Developer of small molecules to treat novel drug resistance pathways in cancer therapy.

37
$20M · Series A BioMedPartners, Altos Ventures, Redalpine 1 to 10 Health Tech, Biotech Zürich, Switzerland •••••••••••@tolremo.com
Alithea Genomics

RNA sequencing and transcriptomics analysis platform.

37
$3M · Seed Novalis Biotechnology Incubation, TechU Ventures, Foundation for Technological Innovation (FIT) 1 to 10 Health Tech, Biotech B2B Lausanne, Switzerland •••••••••••@alitheagenomics.com
LimmaTech Biologics

Self-adjuvanting and multi-antigen vaccine technology platform.

37
$3M · Series A AXA Investment Managers, Novo A/S, Adjuvant Capital 11 to 50 Health Tech, Biotech Zürich, Switzerland •••••••••••@lmtbio.com
Biolytica

Program to increase human lifespan.

31
$5M · Seed Maximon 11 to 50 Health Tech, Biotech B2C Zug, Switzerland •••••••••••@biolytica.com
Epiterna

Manufacturer of drugs to combat the effects of ageing.

31
$10M · Series A Prima Materia 11 to 50 Health Tech, Biotech B2C Lausanne, Switzerland •••••••••••@epiterna.com
EBAMed

Non-invasive treatment for heart arrhythmias.

31
$15M · Series A EIC Accelerator, Panakes Partners 1 to 10 Health Tech, Biotech B2B Geneva, Switzerland •••••••••••@eba-med.com
GlycoEra

Glycanengineering platform.

31
$49M · Series A Sofinnova Partners 11 to 50 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@glycoera.com
Aesyra

Accurate monitoring and treatment platform for sleep bruxism and sleep apnea.

31
$3M · Seed Zürcher Kantonal Bank, Supermoon Capital, Creadd Ventures 1 to 10 Health Tech, Biotech Lausanne, Switzerland •••••••••••@aesyra.com
Nanolive

Nanolive has developed a disruptive proprietary technology.

26
$20M Swisscom Ventures 1 to 10 Health Tech, Biotech, Pharma, Manufacturing, Business Intelligence B2B, SaaS Lausanne, Switzerland •••••••••••@nanolive.ch
Planetary

Planetary uses biomass and precision fermentation techniques to create meat and dairy alternatives.

26
$8M · Seed XAnge, Astanor Ventures, Nucleus Capital 11 to 50 Foodtech, Biotech, Manufacturing B2B Geneva, Switzerland •••••••••••@planetarygroup.ch
Scailyte

True precision medicine through single-cell science

26
$1M · Series A Verve Ventures, Swisscom Ventures 11 to 50 Health Tech, AI, Biotech B2B Basel, Switzerland •••••••••••@scailyte.com
BioVersys

Novel antiobiotic researcher to fight antimicrobial resistance.

26
$8M · Series C AMR Action Fund 1 to 10 Biotech, Pharma B2B Basel, Switzerland •••••••••••@bioversys.com
Engimmune Therapeutics

Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.

26
$15M · Seed Novo A/S, Pureos Bioventures 1 to 10 Health Tech, Biotech, Manufacturing B2B Basel, Switzerland •••••••••••@engimmune.com
iOnctura

Clinical-stage biotechnology developing treatments for cancer.

26
$15M · Series B EIC Accelerator 11 to 50 Biotech Geneva, Switzerland •••••••••••@ionctura.com
Microcaps

Microcaps develops a novel technology that enables the scalable production of precise microcapsules and microparticles.

26
$5M · Seed Helvetica Capital 1 to 10 Health Tech, Biotech, Manufacturing B2B Zürich, Switzerland •••••••••••@microcaps.ch
NewBiologix

Gene and cell therapy manufacturing.

26
$50M · Series A 101 to 250 Biotech Lausanne, Switzerland •••••••••••@newbiologix.com
Pharvaris

Pharvaris is a clinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients.

23
$80M · Series C 11 to 50 Health Tech, Biotech, Deep Tech, Pharma B2B Zug, Switzerland •••••••••••@pharvaris.com
Invasight

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.

21
$4M · Seed High-Tech Gründerfonds, Verve Ventures 1 to 10 Health Tech, Biotech, Deep Tech B2B Zürich, Switzerland •••••••••••@invasight.com
Qnami

Qnami develops quantum sensing technologies designed for nanoscale imaging.

21
$2M · Seed Quantonation, High-Tech Gründerfonds, Verve Ventures 11 to 50 Health Tech, Hardware, Biotech, Navigation and Mapping, Manufacturing B2B Basel, Switzerland •••••••••••@qnami.ch
Vector BioPharma

Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics.

20
$30M · Series A 11 to 50 Health Tech, Biotech, Deep Tech B2B Basel, Switzerland •••••••••••@vectorbiopharma.com
T3 Pharmaceuticals

T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.

20
$26M · Series C 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Basel, Switzerland •••••••••••@t3pharma.com
Cimeio Therapeutics

Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.

20
$50M · Series A 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B Basel, Switzerland •••••••••••@cimeio.com
Rejuveron Life Sciences

Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies.

20
$25M · Series A 1 to 10 Health Tech, Fintech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@rejuveron.com
BC Platforms

BC Platforms is a data and technology company providing tools to advance the development of personalized medicine and precision medicine.

20
$20M 51 to 100 Health Tech, Biotech, Deep Tech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Zürich, Switzerland •••••••••••@bcplatforms.com
Navignostics

Navignostics aims to identify the ideal treatment to each cancer patient’s disease.

17
$7M 1 to 10 Health Tech, Hardware, Biotech, Deep Tech, Pharma Zürich, Switzerland •••••••••••@navignostics.com
Adaptyv Biosystems

Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and nanofluidics.

17
$125k · Pre Seed Y Combinator, Wingman Ventures 1 to 10 Health Tech, Biotech, Deep Tech, Manufacturing B2B Lausanne, Switzerland •••••••••••@adaptyvbio.com
Araris Biotech

Developer of an antibody-drug conjugates (ADCs).

17
$110k · Pre Seed btov Partners, Pureos Bioventures, Redalpine 1 to 10 Health Tech, Biotech B2B Zürich, Switzerland •••••••••••@ararisbiotech.com
Bionomous

Bionomous develops devices that automatically inspect and sort miniature biological entities.

17
$166k · Pre Seed Venture Kick 1 to 10 Health Tech, Biotech, Machine Learning, Manufacturing B2B Lausanne, Switzerland •••••••••••@bionomous.ch
Chord Therapeutics

Chord Therapeutics is a clinical stage biopharmaceutical company developing drugs for rare diseases.

17
$16M · Series A 11 to 50 Health Tech, Biotech, Pharma B2B Geneva, Switzerland •••••••••••@chordtherapeutics.com
Flowbone

We engineered the first injectable biomaterial that stimulated the body's natural ossification process for rapid bone repair & strengthening

17
$166k · Pre Seed Venture Kick 1 to 10 Health Tech, Hardware, Biotech, Deep Tech, Pharma, Manufacturing, ElderTech B2B Lausanne, Switzerland •••••••••••@flowbone.com
Groam

Groam provide bio-based and biodegradable foam solutions for fast disposables.

17
$161k · Pre Seed Venture Kick Agritech, Biotech, Energy & Nuclear, Manufacturing B2B Zürich, Switzerland •••••••••••@groamtech.com
ImmunOs Therapeutics

Immunotherapy platform for cancer.

17
$330k · Pre Seed Lightspeed Venture Partners, BioMedPartners, Gimv 11 to 50 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@immunostherapeutics.com
Neurosoft Bioelectronics

Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the nervous system.

17
$169k · Pre Seed Venture Kick 1 to 10 Health Tech, Hardware, Biotech, Deep Tech, Manufacturing B2B Geneva, Switzerland •••••••••••@neurosoft-bio.com
NextImmune

NextImmune is a privately held biotechnology company.

17
$154k · Pre Seed Venture Kick Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@nextimmune.com
Rheon Medical

Rheon focuses on the development of first-in-class glaucoma drainage devices.

17
$6M 1 to 10 Health Tech, Hardware, Biotech, Manufacturing B2B Lausanne, Switzerland •••••••••••@rheonmedical.com
rqmicro

Rqmicro develops a pathogen separation and detection technology that delivers accurate results in less than 2 hours

17
$6M · Series B 11 to 50 Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence B2B Zürich, Switzerland •••••••••••@rqmicro.com
Testmate Health

Testmate Health builds self-testing kits that allow you you skip the waiting room & get results at home in minutes.

17
$1M · Seed Next Ventures 1 to 10 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing B2B, B2C Lausanne, Switzerland •••••••••••@testmatehealth.com
Versameb

Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.

17
$6M · Seed 1 to 10 Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@versameb.com
Virometix

Virometix is a privately held biotechnology company developing

17
$8M · Series B 11 to 50 Health Tech, Biotech B2B Zürich, Switzerland •••••••••••@virometix.com
Resistell AG

Antibiotic resistance test.

17
$9M · Series B 1 to 10 Biotech, Deep Tech Basel, Switzerland •••••••••••@resistell.com
MPC Therapeutics

Compounds for immunotherapy and metabolic diseases.

17
$1M · Seed Plutus Investment Group 1 to 10 Biotech Geneva, Switzerland •••••••••••@mpc-therapeutics.com
Phialogics

Next-gen IgV therapeutics developer.

17
$656k · Pre Seed High-Tech Gründerfonds 1 to 10 Biotech Basel, Switzerland •••••••••••@phialogics.com
Novostia

Clinical stage artificial heart valve.

17
$2M · Series A 1 to 10 Biotech B2C Bern, Switzerland •••••••••••@novostia.com
Nanoflex Robotics

Medical robotics company.

17
$12M · Series A 11 to 50 Biotech Zürich, Switzerland •••••••••••@nanoflexrobotics.com
Ymmunobio

Preclinical-stage oncology platform.

17
$1M · Seed 1 to 10 Health Tech, Biotech Basel, Switzerland •••••••••••@ymmunobio.com
AERA Health

Preventive health technology.

14
$4M · Pre Seed 11 to 50 Health Tech, Biotech Basel, Switzerland •••••••••••@aera.health
MaxWell Biosystems

MaxWell Biosystems provides solutions to advance basic neuroscience research and accelerate preclinical drug discovery.

14
$4M · Series A 11 to 50 Health Tech, Biotech, Manufacturing B2B Basel, Switzerland •••••••••••@mxwbio.com
Aspivix

ASPIVIX is developing a device that makes gynecological procedures more comfortable for patients.

14
$5M 1 to 10 Health Tech, Hardware, Biotech, Manufacturing B2B Lausanne, Switzerland •••••••••••@aspivix.com
Bloom Biorenewables Ltd

Bloom Biorenewables is making biomass a true alternative to petroleum.

14
$3M 1 to 10 Climate Tech & Green Tech, Biotech, Pharma, Energy & Nuclear, Manufacturing B2B Fribourg, Switzerland •••••••••••@bloombiorenewables.com
Medyria

Guided medical devices cardiovascular procedures.

14
$4M · Series B 1 to 10 Biotech Zürich, Switzerland •••••••••••@medyria.com
Molecule

Molecule is a software platform used to accelerate innovation in the pharmaceutical industry.

12
N/A BACKED VC, Speedinvest, BoxGroup 11 to 50 Health Tech, Fintech, Crypto & web3, Biotech, Deep Tech, Pharma B2B, Marketplace Schaffhausen, Switzerland •••••••••••@molecule.to
Comphya

Comphya developing an active implantable medical device to restore the erectile function of patient non-responsive to oral drugs.

10
$833k · Pre Seed 1 to 10 Health Tech, Biotech, Deep Tech, Manufacturing B2B Lausanne, Switzerland •••••••••••@comphya.com
Aequicens

AI-powered biotech research platform.

10
$110k · Pre Seed 1 to 10 Biotech, Data and Analytics B2B, SaaS Geneva, Switzerland •••••••••••@aequicens.com
Biosimo

Biosimo Chemicals produces sustainable chemicals

10
$308k · Pre Seed 1 to 10 Biotech, Deep Tech, Proptech & Real Estate, Manufacturing B2B Zürich, Switzerland •••••••••••@biosimo-chemicals.com
Ovomind

OVOMIND proposes a new way to share and interact with video games by adding a new dimension: Emotions.

10
$1M 1 to 10 Gaming, Biotech, Data and Analytics, Business Intelligence B2B, SaaS Geneva, Switzerland •••••••••••@ovomind.com
Vatorex

Vatorex enhances honey bee health through an effective and practicable hyperthermic system to fight the varroa mite.

10
$1M 1 to 10 Climate Tech & Green Tech, Agritech, Hardware, Biotech B2B Zürich, Switzerland •••••••••••@vatorex.ch
DeepSquare

The Tokenised Cloud - Sustainable, Decentralised

10
$2M · Pre Seed 11 to 50 Climate Tech & Green Tech, Health Tech, Crypto & web3, Biotech, Deep Tech, Manufacturing B2B, SaaS Zug, Switzerland •••••••••••@deepsquare.io
AC BioScience

AC BioScience is a biotech company that develops personalized molecular therapies designed for cancer patients.

10
$1M · Seed 11 to 50 Health Tech, Biotech B2B Lausanne, Switzerland •••••••••••@ac-bioscience.com
SoHHytec

SoHHytec provides renewable system for onsite production of solar fuel and power which is cleaner, greener, and cost-effective.

10
$2M · Seed 1 to 10 Climate Tech & Green Tech, Biotech, Energy & Nuclear, Manufacturing B2B Lausanne, Switzerland •••••••••••@sohhytec.com